Aspergillosis Terminated Phase 4 Trials for Micafungin (DB01141)

Also known as: Piedra / Aspergillosis NOS / Aspergillus infection / Aspergillus infection NOS / Aspergillus infections

IndicationStatusPhase
DBCOND0020999 (Aspergillosis)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02646800Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus SppTreatment